Table 1.
Anthropometric, thyroid, and metabolic characteristics in PCOS women with untreated SCH (non-treatment), treated SCH (treatment), and normal thyroid function (control).
| Variable | Group | p Value | ||
|---|---|---|---|---|
| Non-treatment n = 38 | Treatment n = 76 | Control n = 76 | ||
| Age (years) | 24.21 ± 4.19 | 25.24 ± 4.29 | 24.80 ± 3.92 | 0.4 |
| BMI (kg/m2) | 26.17 ± 7.01 | 27.12 ± 5.59 | 25.05 ± 6.44 | 0.01 |
| TSH (mIU/L) (0.27–4.2) | 5.58 ± 1.55 | 2.09 ± 0.92 | 1.62 ± 0.54 | <0.0001 |
| FT4 (pmol/L) (9.01–21.88) | 13.42 ± 2.12 | 15.85 ± 2.58 | 13.69 ± 1.70 | <0.001 |
| CHOL (mmol/l) (<5.2) | 4.89 ± 0.92 | 4.77 ± 0.9 | 4.72 ± 0.75 | 0.7 |
| HDL-C (mmol/l) (>1) | 1.35 ± 0.38 | 1.32 ± 0.33 | 1.46 ± 0.42 | 0.1 |
| LDL-C (mmol/l) (<3.4) | 2.94 ± 0.9 | 2.85 ± 0.76 | 2.77 ± 0.72 | 0.7 |
| TRIG (mmol/l) (<1.7) | 1.34 ± 0.58 | 1.33 ± 0.64 | 1.17 ± 0.5 | 0.3 |
| Glucose (mmol/l) (4.08–5.84) | 4.79 ± 0.35 | 4.88 ± 0.39 | 4.83 ± 0.62 | 0.5 |
| Insulin [uIU/ml] (<24) | 11.08 ± 7.26 | 10.40 ± 6.00 | 9.44 ± 6.12 | 0.2 |
| HOMA-IR | 2.41 ± 1.67 | 2.31 ± 1.44 | 2.10 ± 1.57 | 0.2 |
BMI, body mass index; FT4 – free thyroxine; CHOL, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, light-density lipoprotein cholesterol; TRIG, triglycerides; HOMA-IR, homeostatic assessment of insulin resistance.